Atomistry » Bromine » PDB 6pv8-6ror » 6rc0
Atomistry »
  Bromine »
    PDB 6pv8-6ror »
      6rc0 »

Bromine in PDB 6rc0: Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative

Enzymatic activity of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative

All present enzymatic activity of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative:
2.7.1.23;

Protein crystallography data

The structure of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative, PDB code: 6rc0 was solved by M.Gelin, G.Labesse, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 37.52 / 2.75
Space group I 2 2 2
Cell size a, b, c (Å), α, β, γ (°) 62.110, 78.190, 117.960, 90.00, 90.00, 90.00
R / Rfree (%) 22.6 / 25.2

Bromine Binding Sites:

The binding sites of Bromine atom in the Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative (pdb code 6rc0). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative, PDB code: 6rc0:

Bromine binding site 1 out of 1 in 6rc0

Go back to Bromine Binding Sites List in 6rc0
Bromine binding site 1 out of 1 in the Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br302

b:63.8
occ:0.70
 BR1 A:JXH302 0.0 63.8 0.7
C2 A:JXH302 1.8 63.5 0.7
N1 A:JXH302 2.7 63.9 0.7
N3 A:JXH302 2.8 63.4 0.7
C7 A:JXH302 3.0 66.2 0.7
C6 A:JXH302 3.3 65.6 0.7
CB A:ASP45 3.6 47.8 1.0
C A:ASP45 3.7 49.7 1.0
ND2 A:ASN122 3.7 40.9 1.0
O A:ASP45 3.7 50.2 1.0
CD2 A:LEU49 3.7 53.2 1.0
N A:GLY46 3.7 50.8 1.0
C1 A:JXH302 3.8 63.4 0.7
C3 A:JXH302 3.8 63.2 0.7
CA A:GLY46 4.0 52.6 1.0
O1 A:JXH302 4.2 66.4 0.7
CA A:ASP45 4.3 48.8 1.0
C8 A:JXH302 4.4 66.3 0.7
O A:HOH432 4.4 43.0 1.0
CB A:LEU49 4.5 50.3 1.0
CG A:LEU49 4.6 51.4 1.0
CD1 A:LEU49 4.8 49.1 1.0
CG A:ASP45 4.9 45.8 1.0
CG A:ASN122 4.9 39.1 1.0

Reference:

M.Gelin, J.Paoletti, M.A.Nahori, V.Huteau, C.Leseigneur, G.Jouvion, L.Dugue, D.Clement, J.L.Pons, L.Assairi, S.Pochet, G.Labesse, O.Dussurget. From Substrate to Fragments to Inhibitor Activein Vivoagainststaphylococcus Aureus. Acs Infect Dis. 2020.
ISSN: ESSN 2373-8227
PubMed: 32017533
DOI: 10.1021/ACSINFECDIS.9B00368
Page generated: Mon Jul 7 10:19:27 2025

Last articles

Ca in 1FE5
Ca in 1FBL
Ca in 1FDK
Ca in 1FCE
Ca in 1FAT
Ca in 1FBW
Ca in 1FBO
Ca in 1FAK
Ca in 1FAX
Ca in 1F9K
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy